UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pharmacology of human trace amine-associated receptors: Therapeutic opportunities and challenges

Pharmacology & therapeutics (Oxford), 2017-12, Vol.180, p.161-180

2017

Volltextzugriff (PDF)

Monoamine transporter and receptor interaction profiles of novel psychoactive substances: Para-halogenated amphetamines and pyrovalerone cathinones

European neuropsychopharmacology, 2015-03, Vol.25 (3), p.365-376

2015

Volltextzugriff (PDF)

Opioid‐induced inhibition of the human 5‐HT and noradrenaline transporters in vitro: link to clinical reports of serotonin syndrome

British journal of pharmacology, 2018-02, Vol.175 (3), p.532-543

2018

Volltextzugriff (PDF)

Pharmacological profile of novel psychoactive benzofurans

British journal of pharmacology, 2015-07, Vol.172 (13), p.3412-3425

2015

Volltextzugriff (PDF)

Pronounced Hyperactivity, Cognitive Dysfunctions, and BDNF Dysregulation in Dopamine Transporter Knock-out Rats

The Journal of neuroscience, 2018-02, Vol.38 (8), p.1959-1972

2018

Volltextzugriff (PDF)

The Pharmacological Profile of Second Generation Pyrovalerone Cathinones and Related Cathinone Derivative

International journal of molecular sciences, 2021-08, Vol.22 (15), p.8277

2021

Volltextzugriff (PDF)

TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity

Proceedings of the National Academy of Sciences - PNAS, 2011-05, Vol.108 (20), p.8485-8490

2011

Volltextzugriff (PDF)

Duloxetine inhibits effects of MDMA ("ecstasy") in vitro and in humans in a randomized placebo-controlled laboratory study

PloS one, 2012-05, Vol.7 (5), p.e36476

2012

Volltextzugriff (PDF)

Trace Amine-Associated Receptor 1 Agonists as Narcolepsy Therapeutics

Biological psychiatry (1969), 2017-11, Vol.82 (9), p.623-633

2017

Volltextzugriff (PDF)

TAAR1 Expression in Human Macrophages and Brain Tissue: A Potential Novel Facet of MS Neuroinflammation

International journal of molecular sciences, 2021-10, Vol.22 (21), p.11576

2021

Volltextzugriff (PDF)

selective antagonist EPPTB reveals TAAR1-mediated regulatory mechanisms in dopaminergic neurons of the mesolimbic system

Proceedings of the National Academy of Sciences - PNAS, 2009-11, Vol.106 (47), p.20081-20086

2009

Volltextzugriff (PDF)

Trace amine-associated receptor 1 modulates dopaminergic activity

The Journal of pharmacology and experimental therapeutics, 2008-03, Vol.324 (3), p.948-956

2008

Volltextzugriff (PDF)

Receptor Interaction Profiles of 4-Alkoxy-3,5-Dimethoxy-Phenethylamines (Mescaline Derivatives) and Related Amphetamines

Frontiers in pharmacology, 2022-02, Vol.12, p.794254-794254

2022

Volltextzugriff (PDF)

Trace Amines and Their Receptors

Pharmacological reviews, 2018-07, Vol.70 (3), p.549-620

2018

Volltextzugriff (PDF)

Trace Amine-Associated Receptor 1 Regulates Wakefulness and EEG Spectral Composition

Neuropsychopharmacology (New York, N.Y.), 2017-05, Vol.42 (6), p.1305-1314

2017

Volltextzugriff (PDF)

Receptor Interaction Profiles of 4-Alkoxy-Substituted 2,5-Dimethoxyphenethylamines and Related Amphetamines

Frontiers in pharmacology, 2019-11, Vol.10, p.1423-1423

2019

Volltextzugriff (PDF)

In vitro and in vivo metabolism of psilocybin's active metabolite psilocin

Frontiers in pharmacology, 2024-04, Vol.15, p.1391689-1391689

2024

Volltextzugriff (PDF)

The impact of Bdnf gene deficiency to the memory impairment and brain pathology of APPswe/PS1dE9 mouse model of Alzheimer's disease

PloS one, 2013-07, Vol.8 (7), p.e68722-e68722

2013

Volltextzugriff (PDF)

Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens

European neuropsychopharmacology, 2016-08, Vol.26 (8), p.1327-1337

2016

Volltextzugriff (PDF)

The antidepressant-like effects of glutamatergic drugs ketamine and AMPA receptor potentiator LY 451646 are preserved in bdnf+/− heterozygous null mice

Neuropharmacology, 2012-01, Vol.62 (1), p.391-397

2012

Volltextzugriff (PDF)

Antisense oligonucleotide treatment rescues UBE3A expression and multiple phenotypes of an Angelman syndrome mouse model

JCI insight, 2021-08, Vol.6 (15)

2021

Volltextzugriff (PDF)

Selective antagonists of mouse trace amine-associated receptor 1 (mTAAR1): Discovery of EPPTB ( RO5212773)

Bioorganic & medicinal chemistry letters, 2011-02, Vol.21 (4), p.1227-1231

2011

Volltextzugriff (PDF)

Trace amine-associated receptors form structurally and functionally distinct subfamilies of novel G protein-coupled receptors

Genomics (San Diego, Calif.), 2005-03, Vol.85 (3), p.372-385

2005

Volltextzugriff (PDF)

Incretin-like effects of small molecule trace amine-associated receptor 1 agonists

Molecular metabolism (Germany), 2016-01, Vol.5 (1), p.47-56

2016

Volltextzugriff (PDF)

Acetylcholinesterase inhibitors rapidly activate Trk neurotrophin receptors in the mouse hippocampus

Neuropharmacology, 2011-12, Vol.61 (8), p.1291-1296

2011

Volltextzugriff (PDF)

1 – 25 von 99

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(95)
Mit Volltextzugriff
(89)

Publikationsform

Artikel
(97)
Buchkapitel
(2)

Sprache

Englisch
(99)
Japanisch
(19)

Erscheinungsjahr

n.n

Thema

Science & Technology
(78)
Life Sciences & Biomedicine
(73)
Animals
(51)
Pharmacology & Pharmacy
(47)
Neurosciences
(39)
Humans
(36)
Neurosciences & Neurology
(36)
Mice
(24)
Dopamine
(21)
Male
(19)
Hek293 Cells
(18)
Psychiatry
(18)
Rats
(18)
Receptors, G-Protein-Coupled - Metabolism
(18)
Receptors, G-Protein-Coupled - Agonists
(15)
Serotonin
(14)
Pharmacology
(11)
Female
(10)
Dose-Response Relationship, Drug
(9)
Oxazoles - Pharmacology
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pharmacology of human trace amine-associated receptors: Therapeutic opportunities and challenges

Monoamine transporter and receptor interaction profiles of novel psychoactive substances: Para-halogenated amphetamines and pyrovalerone cathinones

Opioid‐induced inhibition of the human 5‐HT and noradrenaline transporters in vitro: link to clinical reports of serotonin syndrome

Pharmacological profile of novel psychoactive benzofurans

Pronounced Hyperactivity, Cognitive Dysfunctions, and BDNF Dysregulation in Dopamine Transporter Knock-out Rats

The Pharmacological Profile of Second Generation Pyrovalerone Cathinones and Related Cathinone Derivative

TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity

Duloxetine inhibits effects of MDMA ("ecstasy") in vitro and in humans in a randomized placebo-controlled laboratory study

Trace Amine-Associated Receptor 1 Agonists as Narcolepsy Therapeutics

TAAR1 Expression in Human Macrophages and Brain Tissue: A Potential Novel Facet of MS Neuroinflammation

selective antagonist EPPTB reveals TAAR1-mediated regulatory mechanisms in dopaminergic neurons of the mesolimbic system

Trace amine-associated receptor 1 modulates dopaminergic activity

Receptor Interaction Profiles of 4-Alkoxy-3,5-Dimethoxy-Phenethylamines (Mescaline Derivatives) and Related Amphetamines

Trace Amines and Their Receptors

Trace Amine-Associated Receptor 1 Regulates Wakefulness and EEG Spectral Composition

Receptor Interaction Profiles of 4-Alkoxy-Substituted 2,5-Dimethoxyphenethylamines and Related Amphetamines

In vitro and in vivo metabolism of psilocybin's active metabolite psilocin

The impact of Bdnf gene deficiency to the memory impairment and brain pathology of APPswe/PS1dE9 mouse model of Alzheimer's disease

Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens

The antidepressant-like effects of glutamatergic drugs ketamine and AMPA receptor potentiator LY 451646 are preserved in bdnf+/− heterozygous null mice

Antisense oligonucleotide treatment rescues UBE3A expression and multiple phenotypes of an Angelman syndrome mouse model

Selective antagonists of mouse trace amine-associated receptor 1 (mTAAR1): Discovery of EPPTB ( RO5212773)

Trace amine-associated receptors form structurally and functionally distinct subfamilies of novel G protein-coupled receptors

Incretin-like effects of small molecule trace amine-associated receptor 1 agonists

Acetylcholinesterase inhibitors rapidly activate Trk neurotrophin receptors in the mouse hippocampus

Suchergebnisse filtern